Atul Dandekar

Companies

• Maze Therapeutics, Inc.CSBO Jan 30, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMaze Therapeutics, Inc. MAZE32,316 shares²$981.3K at $30.36Sep 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 3, 2026Sold 36 shares at $25.81 of Maze Therapeutics, Inc.²
• Sep 3, 2026Sold 3,207 shares at $26.01 of Maze Therapeutics, Inc.²
• Sep 2, 2026Sold 391 shares at $27.12 of Maze Therapeutics, Inc.²
• Sep 2, 2026Sold 2,800 shares at $26.38 of Maze Therapeutics, Inc.²
• Sep 1, 2026Exercised options 12,500 shares of Maze Therapeutics, Inc.³
• Aug 28, 2026Sold 7,500 shares at $27.58 of Maze Therapeutics, Inc.⁴
• Aug 28, 2026Exercised options 7,500 shares at $10.42 of Maze Therapeutics, Inc.⁴
• Jul 29, 2026Sold 400 shares at $27.89 of Maze Therapeutics, Inc.⁵
• Jul 29, 2026Sold 7,100 shares at $27.31 of Maze Therapeutics, Inc.⁵
• Jul 29, 2026Exercised options 7,500 shares at $10.42 of Maze Therapeutics, Inc.⁵
• Jun 29, 2026Sold 7,500 shares at $28.02 of Maze Therapeutics, Inc.⁶
• Jun 29, 2026Exercised options 7,500 shares at $10.42 of Maze Therapeutics, Inc.⁶
• May 29, 2026Sold 7,500 shares at $26.34 of Maze Therapeutics, Inc.⁷
• May 29, 2026Exercised options 7,500 shares at $10.42 of Maze Therapeutics, Inc.⁷
• May 4, 2026Exercised options 5,985 shares at $10.42 of Maze Therapeutics, Inc.⁸
• May 4, 2026Exercised options 8,320 shares at $10.42 of Maze Therapeutics, Inc.⁸
• Apr 29, 2026Sold 7,500 shares at $25.37 of Maze Therapeutics, Inc.⁹
• Apr 29, 2026Exercised options 7,500 shares at $10.42 of Maze Therapeutics, Inc.⁹
• Mar 30, 2026Sold 790 shares at $30.02 of Maze Therapeutics, Inc.¹⁰
• Mar 30, 2026Sold 6,710 shares at $29.26 of Maze Therapeutics, Inc.¹⁰
• Mar 30, 2026Exercised options 7,500 shares at $10.42 of Maze Therapeutics, Inc.¹⁰
• Feb 27, 2026Sold 3,761 shares at $45.72 of Maze Therapeutics, Inc.¹¹
• Feb 27, 2026Sold 3,739 shares at $45.13 of Maze Therapeutics, Inc.¹¹
• Feb 27, 2026Exercised options 7,500 shares at $10.42 of Maze Therapeutics, Inc.¹¹
• Jan 29, 2026Sold 2,800 shares at $45.01 of Maze Therapeutics, Inc.¹²